Cronos Unveils its New CBC Product: Spinach FEELZ™ Day Trip Gummies With THC+CBC
07 déc. 2022 07h30 HE
|
Cronos Group Inc.
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced the launch of a CBC-focused product, the...
Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference
29 nov. 2022 16h35 HE
|
Cronos Group Inc.
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein,...
Cronos Group Appoints James Holm as Chief Financial Officer
14 nov. 2022 07h30 HE
|
Cronos Group Inc.
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of...
Cronos Group Reports 2022 Third Quarter Results
07 nov. 2022 07h30 HE
|
Cronos Group Inc.
Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis, consolidated net revenue increased 7% year-over-year to $21.8 million Reported net...
Cronos Group Inc. Announces Final Settlement Agreements
24 oct. 2022 17h44 HE
|
Cronos Group Inc.
TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that it has reached final settlement agreements with each of the...
Cronos Group Inc. to Hold 2022 Third Quarter Earnings Conference Call on November 7, 2022
17 oct. 2022 16h15 HE
|
Cronos Group Inc.
TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 third quarter earnings conference call on Monday, November 7,...
Cronos Group Reports 2022 Second Quarter Results
09 août 2022 07h30 HE
|
Cronos Group Inc.
Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022 Israel net revenue increased by 212% year-over-year to $7.2 million in Q2 2022 Announced achievement of THCV...
Cronos Group Inc. to Hold 2022 Second Quarter Earnings Conference Call on August 9, 2022
13 juil. 2022 07h30 HE
|
Cronos Group Inc.
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 second quarter earnings conference call on Tuesday, August 9,...
Cronos Group Partners with Geocann to Leverage VESIsorb® Delivery Technology for Faster Absorption
27 juin 2022 07h30 HE
|
Cronos Group Inc.
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is pleased to announce the launch of the first of what is expected to be a range...
Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders
24 juin 2022 16h05 HE
|
Cronos Group Inc.
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the...